Fourth quarter gross margin is expected to be in the range of 73%-75%, compared to 71% in the fourth quarter of 2024, and 70% in the third quarter of 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSO:
- Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
- CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
- CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
- CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
- CytoSorbents implemented workforce and cost reduction program